These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4439055)

  • 1. [Nephrotic syndrome of drug allergy etiology].
    Severova EIa
    Sov Med; 1974 Nov; (11):101-4. PubMed ID: 4439055
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome after treatment with 5-aminosalicylic acid.
    Novis BH; Korzets Z; Chen P; Bernheim J
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1442. PubMed ID: 3132281
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethambutol treatment of tuberculosis in a controlled trial.
    Segarra FO; Lorian V; Sherman DS
    Scand J Respir Dis; 1968; 49(3):202-6. PubMed ID: 4980226
    [No Abstract]   [Full Text] [Related]  

  • 4. Madras Study of intermittent oral chemotherapy.
    Tripathy SP
    Bull Int Union Tuberc; 1972 Feb; 47():30-6. PubMed ID: 5077117
    [No Abstract]   [Full Text] [Related]  

  • 5. [An experience in the use of pasomycin in tuberculosis of the lungs].
    Gavril'ev SS
    Antibiotiki; 1966 Jan; 11(1):78-83. PubMed ID: 4166232
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of allergy to antituberculous drugs (PAS, SM and INH) in tuberculous patients.
    Brown H; Jennings TS; Coleman EO; Bulubash V
    Med Ann Dist Columbia; 1966 Dec; 35(12):652-7 passim. PubMed ID: 5231829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypersensitivity reactions to antituberculous drugs in pulmonary tuberculosis].
    Dukalski J; Stański K
    Gruzlica; 1969 Oct; 37(10):937-41. PubMed ID: 5366986
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cases of leukopenia caused by PAS allergy].
    Fukui S
    Iryo; 1966 Mar; 20(3):282-5. PubMed ID: 5964835
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance to ethionamid and PAS in original treatment of tuberculous patients.
    Verbist L; Prignot J; Cosemans J; Gyselen A
    Scand J Respir Dis; 1966; 47(4):225-35. PubMed ID: 5182290
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 11. The need for new antituberculous drugs.
    Dahlström G
    Scand J Respir Dis Suppl; 1969; 69():11-3. PubMed ID: 4906370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 14. Disturbances in the thyroid function during the treatment with the para-aminosalicylic acid derivatives.
    Górowski T; Gasiorowski W
    Pol Med J; 1968; 7(3):638-42. PubMed ID: 5669704
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of various compounds of PAS].
    Potworowska M; Wareska W; Lachowicz E; Pecyna-Sielewicz J; Ambroziak-Miller M
    Gruzlica; 1969 Jul; 37(7):673-80. PubMed ID: 4900504
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 17. [INH-induced pellagra in pulmonary tuberculosis].
    Sönnichsen N; Zoellner E; Randow U
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):224-7. PubMed ID: 5899146
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 19. [On a case of simple goiter in a tuberculous subject treated with para-aminosalicylic acid].
    De Sanctis G; Petreni R
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1433-8. PubMed ID: 5760383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.